Informex – companies hope for a brighter 2010

By Nick Taylor

- Last updated on GMT

Related tags: Management, Economics, India, China

There are signs that 2010 will be a better year for the fine and custom chemistry industry but companies at Informex remained cautious and are planning accordingly.

Business from biotechs remains down and large pharma’s focus on cost cutting is squeezing suppliers but overall the industry is healthier than it was 12 months ago.

This has led companies to adopt a reservedly optimistic outlook for the year ahead. Whatever the financial situation, the establishment of strong working relationships and provision of quality, on time services continue to be vital for growing business.

India, China and other emerging markets are making gains in this area but still have work to do.

Related news

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars